Hanzel J, Dreesen E, Vermeire S, Lowenberg M, et al. Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study. Inflamm Bowel Dis 2021 Nov 12. pii: 6426108. doi: 10.1093.
PMID: 34788812